Posted in | News | Optics and Photonics

Canon Develops Blue Spectrum Refractive Element for Correcting Chromatic Aberration in Camera Lenses

Canon U.S.A., Inc., a leader in digital imaging solutions, today announced that its parent company, Canon Inc., has developed Blue Spectrum Refractive (BR), a new optical element for use in camera lenses that corrects chromatic aberrations at an extremely high level to achieve superb imaging performance.

The new Canon-developed BR optical element offers characteristics that significantly refract blue light, which lies within the short-wavelength range, to achieve impressive levels of chromatic aberration correction for outstanding imaging performance. The BR optical element, positioned between two glass lens elements to create a BR lens, will make its debut in the new EF 35mm f/1.4L II USM wide-angle fixed-focal-length lens, which is scheduled to go on sale in October 2015.

Natural light, or white light, comprises a spectrum of wavelengths, or colors, each of which realizes a unique refractive index when passing through a lens. As all colors do not converge on the same point, this disparity causes chromatic aberrations, or color fringing, to occur in an image.

Canon develops optical elements by reviewing organic optical materials, beginning with the design of molecular structures, with the aim of achieving optimal chromatic aberration correction that suppresses color fringing. With the successful development of the BR optical element, which offers unique light-dispersion characteristics that significantly refract blue light—a wavelength that, until now, had proven particularly difficult to converge to a specific focal point—Canon is able to develop lenses that result in outstanding imaging performance by correcting chromatic aberrations at an exceptionally high level.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.